It is a subsidiary of GC Cell and also one of Japan’s leading cell therapy research and sales companies.
In 2015, it obtained a ‘manufacturing specified cell product license’ from the Japanese Ministry of Health,
Labor and Welfare, and currently manufactures and provides cell therapy services.